8.GerardG.Del'obliterationducanalarterial,les
theoriesetlesfaits.JAnat.1900;36:323–357.
9.HuggettA,StG.Foetalblood-gastensionsand
gastransfusionthroughtheplacentaofthefoetal
goat.JPhysiol.1927;62:373–384.
10.MunroJC.Ligationoftheductusarteriosus.Ann
Surg.1907;46:335–338.
11.GraybielA,StriederJW,BoyerNH.Anattempt
toobliteratethepatentductusarteriosusina
patientwithbacterialendocarditis.AmHeartJ.
1938;15:621–624.
12.GrossRE,HubbardJP.Surgicalligationofa
patentductusarteriosus.Areportoffirst
successfulcase.JAMA.1939;112:729–731.
13.GibsonGA.Aclinicallectureonpersistent
ductusarteriosus.MedicalPressandCircular.
[May30th]1906:572–574.
14.TynanM.Themurmurofthepersistentlypatent
arterialduct,or“thecolonelisgoingtoa
dance”.CardiolYoung.2003;13:559–562.
15.HeymannMA,CreasyRK,RudolphAM.
Quantitationofbloodflowpatternsinthefoetal
lambinutero.ProceedingsoftheSirJoseph
BarcroftCentenarySymposium:Foetaland
NeonatalPhysiology.CambridgeUniversity
Press:Cambridge,UK;1973:129–135.
16.ReedKL,MeijboomEJ,SahnDJ,etal.Cardiac
dopplerflowvelocitiesinhumanfetuses.
Circulation.1986;73:41–46.
17.LealSD,Cavalle-GarridoT,RyanG,etal.
Isolatedductalclosureinuterodiagnosedby
fetalechocardiography.AmJPerinatol.
1997;14:205–210.
18.EdwardsJE.Malformationsoftheaorticarch
systemmanifestedas“vascularrings”.Lab
Invest.1953;2:56–75.
19.CongdonED.Transformationoftheaortic-arch
systemduringthedevelopmentofthehuman
embryo.ContrEmbryol.1922;14:47–110.
20.NairSK,SubramanyamR,VenkitachalamCG,
ValiathanMS.Rightaorticarchwithisolationof
theleftsubclavianarteryandbilateralpatent
ductusarteriosus.Acasereport.JCardSurg.
1992;33:242–244.
21.StenoN.Reprintedwithhistoricalnote:an
unusuallyearlydescriptionoftheso-called
tetralogyoffallot.MayoClinProc.
1948;23:316–320.
22.EmmanouilidesGC,ThanopoulosB,SiassiB,
FishbeinM.‘Agenesis’ofductusarteriosus
associatedwiththesyndromeoftetralogyof
fallotandabsentpulmonaryvalve.AmJ
Cardiol.1976;37:403–409.
23.TennisP,ChanK,CurkendallSM,etal.
Topiramateuseduringpregnancyandmajor
conjenitalmalformationsinmultiple
populations.BirthDefectsResAClinMol
Teratol.2015;103:269–275.
24.NoraJJ,NoraAH.Theevolutionofspecific
geneticandenvironmentalcounsellingin
congenitalheartdisease.Circulation.
1978;57:205–213.
25.GilbertEF,BruyereHJJr,IshikawaS,Cheung
MO,HodachRJ.Theeffectofherapyrand
butoxamineonaorticarchmalformationinbeta
adrenoreceptorstimulatedchickembryos.
Teratology.1977;15:317–324.
26.HeymannMA,RudolfAM.Controloftheductus
arteriosus.PhysiolRev.1975;55:62–78.
27.CoceaniF,OlleyPM.Theresponseoftheductus
arteriosustoprostaglandins.CanJPhysiol
Pharmacol.1973;51:220–225.
28.SilverMM,FreedomRM,SilverMD,OlleyPM.
Themorphologyofthehumannewbornductus
arteriosus:areappraisalofitsstructureand
closurewithspecialreferencetoprostaglandin
E1therapy.HumPathol.1981;12:1123–1136.
29.Gittenberger-de-GrootAC,StrengersJL,
MentinkM.Histologicstudiesonnormaland
persistentductusarteriosusinthedog.JAmColl
Cardiol.1985;6:394–404.